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A polymerase chain reaction (PCR) based on a combination of oligonucleotide primers selected using the octamer
frequency disparity method with primers specific for EHV-5 (described by other authors) recognized all of a series of gamma
herpesvirus field isolates. This PCR produced only three fragments: (1) one EHV-2-specific; (2) one EHV-5-specific; and (3)
a fragment that occurred alone or in combination with the other two. Cloning and sequencing of four different isolates
yielding only the last PCR product showed that this corresponds to a deletion/insertion mutant of EHV-2. The fact that this
mutant was also plaque-purified from a culture producing all three PCR fragments demonstrated that the virus producing
this fragment was distinct from the other two and that this specific DNA fragment was not an artefact due to PCR amplification.
These data show that equine gamma herpesviruses are genetically more heterogeneous than previously assumed. The
PCR failed to directly detect gamma herpesviruses from the DNA extracted from the same starting material used for the
isolation of gamma herpesvirus by cocultivation with indicator cells. This demonstrates that the most reliable method for
detection of equine gamma herpesviruses is the cocultivation with indicator cells. q 1997 Academic Press
INTRODUCTION horses after experimental inoculation (Blakeslee et al.,
1975). EHV-2 was more frequently isolated from tracheal
Two gamma herpesviruses have been described in aspirates of foals with respiratory diseases than from
the horse (Telford et al., 1993). Equine herpesvirus 2 healthy foals (Murray et al., 1996).
(EHV-2) was isolated from a horse with upper respiratory The biological, immunopathological, and epidemiolog-
tract disease by Plummer and co-workers (Plummer and ical properties of the gamma herpesviruses in the horse
Waterson, 1963; Plummer et al., 1969). EHV-5 was first are not completely understood A prerequisite for accu-
described by Agius and co-workers (Agius et al., 1992) rate studies in the future is the possibility of distinguish-
and its pathogenetic potential is not completely under- ing the different virus types present in the horse and of
stood because of the frequent occurrence with EHV-2. identifying the truly gamma herpesvirus-negative horses.
EHV-2 is widely distributed in horses in a hidden form. Our study represents a contribution to this goal.
It can be activated and obtained as complete virus by
cocultivation of blood leukocytes with equine or rabbit MATERIALS AND METHODS
indicator cells. EHV-2 was isolated in 86% of horses in
HorsesScotland (Roeder and Scott, 1975), 89% in Iowa (Kemeny
and Pearson, 1970), and 77% in Zurich (Schlocker et al.,
For this study 33 horses aged between 8 and 15 years1995). In a recent study EHV-2 was isolated from 97%
(18 geldings and 15 mares) were recruited. Bronchoal-of abattoir horses in the United Kingdom. The highest
veolar lavage (BAL) was performed on 22 of these horses.frequency of isolation was obtained for bronchial lymph
nodes (85%) (Edington et al., 1994). EHV-2 has not been EHV-2 stock preparation
considered a pathogen because of its wide distribution in
the equine population. Experimental infections, though, Five hundred microliters of EHV-2 (Plummer strain,
ATTC No. VR-701) suspension was added to 2 ml ofshowed that pharyngitis could be induced in foals with
virus shedding through nasal discharge for up to 118 Eagle’s minimal essential medium with Earle’s salts
(EMEM; BioConcept, Allschwil, Switzerland) and used todays. No respiratory tract disease developed in adult
infect a monolayer of equine embryonic lung fibroblasts
(EHL, embrionic horse lung) in a 150-cm2 cell culture
vessel. After 1 h at 377 the suspension was removed andSequence data from this article have been deposited with the EMBL/
GenBank Data Libraries under Accession Nos. AF014391–AF014395. the monolayer was washed once with 30 ml of PBS; 401 To whom correspondence and reprint requests should be ad-
ml of EMEM with 2% fetal calf serum (FCS) was thendressed at University of Zurich, Institute of Veterinary Physiology, Divi-
added to the cells. After 5 days the cytopathic effect wassion of Applied Physiology, Winterthurerstr 260, 8057 Zurich, Switzer-
land. Fax: 01-635 89 32. E-mail: mfra@vetphys.unizh.ch. recognized and at day 6 the cell culture flask was frozen
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at 0207. After two additional freeze–thaw cycles the sus- polymerase (Catalys AG, Wallisellen, Switzerland), and 5
ml of the samples. Thirty-five cycles of amplification werepension was filled in 1-ml vials and frozen at 0707.
performed under following conditions: denaturation, 1
Bronchoalveolar lavage min at 947C; annealing, 1 min at 607C; extension, 1 min
at 727C. Five microliters of the product was loaded onHorses were sedated with a combination of xylazine
1.9% agarose gels containing 0.5 mg ethidium bromideand methadone. A video bronchoscope was introduced
per milliliter.trough the precleaned and topically anesthethised nostril
Primers. Primers and target sequence were chosen inand advanced until it wedged in a bronchus. During the
order to achieve maximal specificity and ideal amplifica-advancement of the bronchoscope the bronchial surface
tion conditions using the octamer frequency disparitywas continuously anesthetised with a solution containing
method by screening the sequence of EHV-2 strain 86/1% lidocaine and 0.9% sodium chloride injected through
67 (Telford et al., 1995) using the Macintosh program PC-a sterile catheter passed through the biopsy channel.
Rare (Griffais et al., 1991). The target sequence is notTwo hundred fifty milliliters of prewarmed sterile physio-
conserved among herpesviruses (forward primer, 5*-logical saline solution was infused through the biopsy
TACATCCTCAAAATCCTGTGAATCGTCCGA-3*; reversechannel into the bronchus and immediately reaspirated
primer, 5*-CGCCGCTGTCCAAAACACCATGTAGCTACG-with a suction pump into a sterile flask. The infusion/
3*). The octamers at their 3* ends are the rare octamersaspiration procedure was repeated three more times in
(frequency in the human genome  0.26 1 1006) chosenthe same lung segment.
by the program. The target sequence is situated in a
noncoding region between positions 40,661 and 41,266Virus isolation
of the EHV-2 sequence, and the expected product length
Mononuclear cells from 10 ml blood were isolated by is 604 bp.
density gradient centrifugation using standard methods The second EHV-2-specific primer set and the EHV-5-
and added to a monolayer of EHL in 25-cm2 flasks in a specific set used were designed by Reubel et al. (1995)
volume of 10 ml EMEM with 10% FCS. Bronchoalveolar and are called EHV-2R and EHV-5 oligonucleotide prim-
lavage cells were collected by centrifugation of the BAL ers. The expected product lengths are 257 and 251 bp,
fluid at 250 g for 15 min at 47 and washed once with PBS respectively.
and 2 1 107 cells were resuspended in a volume of 20 In a first phase a separate PCR amplification for each
ml EMEM with 10% FCS and added to two monolayers of primer set was run. In a second phase a combination of
EHL in 25-cm2 flasks. The medium was removed weekly our primer with the EHV-5 primer was used to detect
together with nonadherent and dead cells and replaced EHV-2 and EHV-5 simultaneously and a parallel PCR was
with fresh medium. When the first signs of infection were run with the EHV-2R primers.
recognizable (rounding up and detachment of fibroblasts Capsid PCR. The primers were designed for amplifica-
from the bottom) the medium was changed, and after 2 tion of a target in the region coding for the major capsid
to 3 days the medium containing the infected cells was protein of EHV-2 (forward primer, 5*-TAGAGAACAGAC-
frozen at 0207. Cultures which remained negative for 8 CCTACCCC-3*; reverse primer: 5*-GCCCCTATGTAC-
weeks were considered negative. TCTGTGAC-3*), which generated fragments of an ex-
Positive controls consisted of monolayers infected pected size of 451 bp.
with aliquots of reference virus. Negative controls were IL 10-like gene PCR. A PCR was performed to amplify
obtained by scraping noninfected EHL monolayers from the region of EHV-2 coding for the interleukin 10-like
25-cm2 flasks with a rubber policeman and collecting the gene (forward primer, 5*-ATGAAGATGTCAAACTCGC-3*;
suspension. reverse primer, 5*-AGGGTAAAGACCTTCTTTCAG-3*).
The expected product length was 350 bp.
Polymerase chain reaction
Sample preparation for PCR. Each 1-ml aliquot of the Sequencing of PCR products
thawed samples was put into a 1.5-ml microcentrifuge
vial and centrifuged at 14,000 g for 10 min at 47. The The amplified products were purified from the agarose
gel using the QiaQuick gel extraction kit (Qiagen AG,supernatants were discarded and 100 ml of a solution
containing 20 mM Tris, 0.1% Triton X-100, and 12 mg/ml Basel, Switzerland) and cloned in the LigATor AT-cloning
Vector pTAg (R&D Systems Europe Ltd., Abington, UK)Proteinase K was added to the pellets. After 1 h incuba-
tion at 567 and 5 min boiling, the vials were centrifuged according to the manufacturer’s instructions. The se-
lected positive plasmids were purified using the Qiagenat 14,000 g for 5 min at 47 and the supernatants were
used as targets in PCR. Plasmid Mini kit (Qiagen AG), and sent for bidirectional
sequencing to a private company with a certified se-PCR conditions. PCR was run in a volume of 20 ml with
50 mM KCl, 10 mM Tris –HCl, 1.5 mM MgCl, 0.1% gela- quencing error rate lower than 0.0078% (Microsynth
GmBH, Balgach, Switzerland). Our internal referencetine, 200 mM each dNTP, 12.5 pmol primer, 1 U of Taq
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TABLE 1 also positive in the BAL. Two horses were positive in the
BAL but negative in the blood (Nos. 1 and 33).Classification of Gamma Herpesvirus Isolates from Different
Horses by PCR
Differentiation between gamma herpesviruses andEHV-2 EHV-5
identification of an EHV-2 variantHorse Isolation 600 EHV-2B 251 EHV-2R
No. froma bp 431 bp bp 257 bp
The results obtained are summarized in Table 2. Direct
EHV-2 ATCC / 0 0 0 detection of gamma herpesviruses using DNA of PBMC
EHV-2B (4)b 0 / 0 0
purified from known positive horses was negative in 31 BAL 0 / 0 0
of 3 horses (Nos. 3, 8, 20). Thus the utility of PCR was2 PBMC / 0 0 0
3 PBMC / / 0 / restricted to the identification of virus type and variants
BAL / / / / in virus-positive material from cocultures. EHV-2 primers
5 PBMC 0 / 0 0 recognized EHV-2 (ATCC), producing a fragment of the
7 PBMC / 0 0 0
correct length of 604 bp (Fig. 1, 1A). In our hands the8 PBMC 0 / 0 0
EHV-2-R primers did not recognize the EHV-2 PlummerBAL / 0 0 /
10 PBMC 0 / 0 0 reference virus strain, but in 16 of the 34 isolates a prod-
11 PBMC 0 / 0 0 uct of the expected length of 257 bp was produced (Fig.
12 PBMC / 0 0 / 1, 2D). The PCR with our EHV-2 primers produced in
13 PBMC / 0 0 /
some isolates a 431-bp fragment in addition to the char-14 PBMC / 0 0 0
acteristic 604-bp band (Figs. 1B and 2, 1B). The virus15 PBMC / 0 0 /
16 PBMC / 0 0 / originating this shorter product was cloned by plaque
18 PBMC / / 0 / purification from an isolate positive for all three products
29 PBMC / / 0 / (horse 22). Subsequently five field isolates were found
21 PBMC / 0 0
that were positive for the 431-bp band exclusively. These22 PBMC / / / /
five isolates were not recognized by the EHV-2R primers.23 PBMC 0 / / 0
26 PBMC / 0 / 0 EHV-5 produced in EHV-5 positive isolates a product of
BAL / 0 / / the expected length of 217 bp (Fig. 1, 3C, 3D). With a
28 PBMC / 0 0 0
combination of the EHV-2 and the EHV-5 primers all 34BAL / 0 0 0
virus isolates were identified. The PCR using capsid29 PBMC / 0 0 /
primers and interleukin 10-like gene primers recognized31 PBMC / 0 0 0
BAL 0 / / 0 the EHV-2 reference and our variant but not EHV-5.
32 PBMC / 0 0 0
BAL 0 / / 0
33 BAL / 0 0 /
TABLE 2
a PBMC, peripheral blood mononuclear cells; BAL, bronchoalveolar Frequency of the Gamma Herpesviruses Isolates
lavage cells.
b Plaque cloned EHV-2 producing in PCR a band of 431 bp. Isolates Horses
N 34 33
strain was sequenced three times from three different Positive by virus isolation 34 24
Positive from PBMC — 22cultures in both orientations. The sequences have been
Positive from BAL — 8/22adeposited in GenBank under Accession Nos. AF014391–
PCR positive using EHV-2 and EHV-5 primers 34 24AF014395.
PCR positive using EHV-2R and EHV-5 primers 21 15
PCR positive using EHV-2R but negative using
EHV-2 primers 0 0RESULTS
PCR positive with EHV-2R primers 16 12
PCR positive with EHV-2 primersFrequency of gamma herpesvirus isolation from blood
(EHV-2/2B positive) 33 24
and BAL EHV-2 positive 25 19
EHV-5 positive 8 6
Twenty-four of 33 horses were virus positive (72%; Ta- EHV-2B positive 16 12
EHV-2/5 positive 4 5ble 2). In Table 1 the isolation of gamma herpesviruses
EHV-2/2B positive 7 7from BAL cells and PBMC of the 24 virus positive horses
EHV-5/2B positive 5 5are documented. Virus was isolated from the blood of 22
EHV-2/5/2B positive 2 4b
horses (66.6%). BAL was performed in 22 of the 33
horses, and 8 (36.4%) were positive for gamma herpesvi- a BAL was performed in 22 of the 33 horses.
b In 2 horses the three viruses were isolated from distinct cultures.rus isolation. From the 22 blood-positive horses 6 were
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with EHV-2 ATCC and EHV-2B produced fragments of
the same length.
Frequency of the different gamma herpesvirus types
Repeated isolations from horses infected with more
than one virus type always produced the same virus
types, but sometimes one or two types failed to replicate
in one or more cocultures. Virus isolation from the BAL
cells was less efficient and required a longer incubation
period than from blood (4–8 weeks vs 2–4 weeks). BAL
cells and PBMC obtained from one horse on the same
day differed sometimes in the gamma herpesvirus types
they bore. EHV-2 was isolated more often from blood,
whereas isolates from BAL contained the three virus
types at a similar frequency (Table 3).
DISCUSSION
The pathogenic effect of equine gamma herpesviruses
is still unclear. Gamma herpesviruses can be isolated
from healthy horses but conjunctivitis, upper respiratory
tract diseases, lower respiratory tract disease in foals,
poor performance, malaise (Browning and Studdert,
1988; Belak et al., 1980; Palfi et al., 1978), and chronic
FIG. 1. PCR amplification using different oligonucleotide primers indi- lung disease (Schlocker et al., 1995) have been associ-
cated in sectors 1–4 and different gamma herpesvirus targets: K, unin- ated with infection. The possibility of distinguishing be-
fected equine lung fibroblasts; A, EHV-2 ATCC reference strain; B, tween different virus types by PCR allows us to investi-
plaque cloned EHV-2 variant B(4), producing a shorter product; C, EHV-
gate whether pathogenicity or tropism are associated5 field isolate; D, field isolate from horse 22, containing all three gamma
with one or more particular types/subtypes different fromherpesvirus types; M, 123-bp DNA ladder (GIBCO BRL, Life Technolo-
gies AG, Basel, Switzerland). those isolated from healthy horses.
Considering that approximately 75% of the horse popu-
lation is infected with gamma herpesviruses (Schlocker
The identified variant is a deletion/insertion mutant of et al., 1995; Kemeny and Pearson, 1970; Roeder and
EHV-2 Scott, 1975), the reliability of the test used is very im-
portant in order to identify the true virus negative horsesThe nucleotide sequence of the 431-bp amplification
and to compare them with the infected population.product was determined after cloning in a sequencing
vector and was compared with the known sequences
in the EMBL/GenBank data banks. The best score of
sequence similarity was found within the EHV-2 se-
quence in the region expected to be amplified from the
reference target. The sequence of the 431-bp PCR prod-
uct obtained by amplification of our plaque-purified EHV-
2 variant (No. 4) was aligned to the EHV-2 strain 86/67
sequence deposited in the GenBank data library under
Accession No. U20824 (Telford et al., 1995), introducing
gaps to obtain an optimal alignment (bestfit). The se-
quence of the variant EHV-2 contains a deletion of 211
bp and two insertions of 37 and 4 bp, respectively (Fig.
3). The PCR product of four further EHV-2 variants directly
amplified from positive cocultures from different horses
at different times were cloned in the pTAg vector and
sequenced bidirectionally using the M13 sequencing
primers. These sequences showed a high degree of simi-
larity with the plaque-purified reference variant strain No. FIG. 2. PCR amplification of EHV-2 ATCC reference strain (A), EHV-
4. The alignment is shown in Fig. 2. We called this variant 2B (B), and EHV-5 (C) using different primers: 1, EHV-2 primers; 2, EHV-
2 capsid primers; and 3, EHV-2 interleukin 10-like gene primers.EHV-2B. The capsid PCR and the IL 10-like gene PCR
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FIG. 3. Sequence alignment of the PCR products obtained from our plaque cloned variant EHV-2B No. 4 (4) and from 4 primary EHV-2B isolates
(55, 283, 293, 355) to the EHV-2 strain 86/67 reference sequence (Telford et al., 1995).
The low frequency of gamma herpesvirus-infected 2R primers and 21 of 34 were positive with the EHV-2R
or EHV-5 primers). We conclude that the most reliablehorses determined by direct PCR by others (Reubel et
method to detect gamma herpesvirus-infected horses isal., 1995) contrasts with the high frequency of gamma
the cocultivation of PBMC with equine fibroblasts. There-herpesvirus isolations in present and other investigations
after PCR may be used for the unequivocal identificationand may be explained by different factors: (1) a geograph-
of the different types. In only some cases were positiveically variable incidence of the infection; (2) the number
results obtained with the PCR after 1 week of cocultiva-of infected cells in peripheral blood may be below the
tion (data not shown), whereas the infection was morpho-detection limit of PCR (between 0.05 and 25 infectious
logically recognized after 2 weeks. Thus the strategy ofcells per 106 PBMC) (Gleeson and Coggins, 1985); and
an early detection of a gamma herpesvirus infection by(3) the described primers are specific for a subpopulation
PCR after 1 week of cocultivation is much less sensitiveof gamma herpesviruses (in our study only 16 of 34 EHV-
than the detection of virus after cocultivation and mor-2- or EHV-5-positive isolates were positive with the EHV-
phological identification.
The lower frequency of virus isolation from BAL cells
TABLE 3 contrasted with the high frequency of isolation from lung
lymph nodes found by other authors (Edington et al.,Relation between Viral Source and Gamma Herpesvirus Type
1994). This was probably due not to the absence of virus
Source N EHV-2 EHV-2B EHV-5 from BAL cells but to the activation of latent microbial
spores present in lung macrophages during cocultiva-
PBMC 24 19 10 3 tion. During cocultivation of BAL cells 11 of the 22 cul-
BAL 10 6 5 5
tures were contaminated by fungal growth before the
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mapping of a new equine herpesvirus with a novel genome structure.time necessary to consider an isolation attempt as nega-
Virology 191, 176–186.tive was over. Our results do not show an exclusive tro-
Belak, S., Palfi, V., Tuboly, S., and Bartha, L. (1980). Passive immuniza-
pism of one virus type for blood or BAL cells but the tion of foals to prevent respiratory disease caused by equine herpes-
predominant virus isolated from PBMC was EHV-2. In virus type 2. Zentralbl Veterinarmed. [B] 27, 826–830.
Blakeslee, J. R., Olsen, R. G., Mc Allister, E. S., Fassbender, J., and Den-the BAL cells the three viruses were isolated with the
nis, R. (1975). Evidence of respiratory tract infection induced bysame frequency, indicating a tendency of EHV-2 to be
equine herpesvirus, type 2, in the horse. Can. J. Microbiol. 21, 1940–more hemotropic and EHV-5 and 2B to be more pneumo- 1946.
tropic. The confirmation of this hypothesis is made diffi- Browning, G. F., and Studdert, G. F. (1988). Equine Herpesvirus 2
(Equine Cytomegalovirus). Vet. Bull. 58, 775–789.cult by the fact that fungal contamination due to phagocy-
Edington, N., Welch, H. M., and Griffiths, L. (1994). The prevalence oftosed fungal spores reduced substantially the isolation
latent equid herpesviruses in the tissues of 40 abbattoir horses.efficiency from BAL samples (antifungal agents were not
Equine Vet. J. 26, 140–142.
added because of the observed inhibition of viral replica- Gleeson, L. J., and Coggins, L. (1985). Equine herpesvirus type 2: Cell–
tion as a consequence of a toxic effect on the cells). virus relationship during persistent cell associated viremia. Am. J.
Vet. Res. 46, 19–23.Our study demonstrates the importance of a reliable
Griffais, R., Andre´, P. M., and Thibon, M. (1991). K-Tuple frequency indiagnostic procedure for the identification of gamma her-
the human genome and polymerase chain reaction. Nucleic Acidspesvirus carriers in the horse population and proposes Res. 19, 3887–3891.
a combination of different PCR oligonucleotide primers Kemeny, L., and Pearson, E. (1970). Isolation of herpesvirus from equine
leucocytes: Comparison with equine pneumonitis virus. Can. J. Comp.in order to identify all the isolates that can be obtained
Med. 34, 56–95.after cocultivation of equine blood or BAL cells with indi-
Kirisawa, R., Endo, A., Iwai, H., and Kawakami, Y. (1993). Detection andcator cell cultures. This primer combination recognized
identification of equine herpesvirus-1 and -4 by polymerase chain
all our isolates, produced fragments of three different reaction. Vet Microbiol. 36, 57–67.
lengths, and revealed the existence of a frequent gamma Murray, M. J., Eichorn, E. S., Dubovi, E. J., Ley, W. B., and Cavey, D. M.
(1996). Equine herpesvirus type 2: Prevalence and seroepidemiologyherpesvirus deletion/insertion mutant distinct from EHV-
in foals. Equine Vet. J. 28, 432–436.2 and EHV-5. Small differences in the sequences of her-
Palfi, V., Belak, S., and Molnar, T. (1978). Isolation of equine herpesvirus
pesviruses may be responsible for different biological type 2 from foals, showing respiratory symptoms. Zentralbl Veteri-
properties. For example, differences in the amplification narmed [B] 25, 165–167.
Plummer, G., and Waterson, A. P. (1963). Equine herpesviruses. Virologyproducts of equine herpesvirus types 1 (EHV-1) and 4
19, 412–416.made it possible to distinguish them in order to evaluate
Plummer, G., Bowling, C. P., and Goodhearth, C. R. (1969). Comparisonthe risk of abortion and paralysis associated with EHV-
of four equine herpesviruses. J. Virol. 4, 738–741.
1 (Wagner et al., 1992; Kirisawa et al., 1993). The isolation Reubel, G. H., Crabb, B. S., and Studdert, M. J. (1995). Diagnosis of
of a mutant of EHV-2 and the fact that the EHV-2R primers equine gammherpesvirus 2 and 5 infections by polymerase chain
reaction. Arch. Virol. 140, 1049–1060.recognized only one part of our field isolates indicates
Roeder, P. L., and Scott, G. R. (1975). The prevalence of equid herpesvi-that gamma herpesviruses are genetically more hetero-
rus 2 infections. Vet. Rec. 96, 404–405.
geneous than previously known. Schlocker, N., Gerber-Bretscher, R., and Von Fellenberg, R. (1995).
Equine herpesvirus 2 in pulmonary macrophages of horses. Am. J.
Vet. Res. 56, 749–754.ACKNOWLEDGMENTS
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